Literature DB >> 9294201

Macrophage inflammatory protein-2: chromosomal regulation in rat small intestinal epithelial cells.

Y Ohno1, J Lee, R D Fusunyan, R P MacDermott, I R Sanderson.   

Abstract

Nonpathogenic, resident bacteria participate in the pathogenesis of inflammation in the small intestine, but the molecular messages produced by such bacteria are unknown. Inflammatory responses involve the recruitment of specific leukocyte subsets. We, therefore, hypothesized that butyrate, a normal bacterial metabolite, may modulate chemokine secretion by epithelial cells, by amplifying their response to proinflammatory signals. We studied the expression of the chemokine, macrophage inflammatory protein-2 (MIP-2) by the rat small intestinal epithelial cell line, IEC-6. Cells were stimulated with lipopolysaccharide or with interleukin 1beta (IL-1beta) and incubated with sodium butyrate. Acetylation of histones was examined in Triton X acetic acid-urea gels by PAGE. Unstimulated IEC-6 cells did not secrete MIP-2. However, lipopolysaccharide and IL-1beta induced MIP-2 expression. Butyrate enhanced MIP-2 secretion both in lipopolysaccharide-stimulated and IL-1beta-stimulated enterocytes; but butyrate alone did not induce MIP-2 expression. Butyrate increased the acetylation of histones extracted from the nuclei of IEC-6 cells. Furthermore, acetylation of histones (induced by trichostatin A, a specific inhibitor of histone deacetylase) enhanced MIP-2 expression by cells stimulated with IL-1beta. In conclusion, trichostatin A reproduced the effects of butyrate on MIP-2 secretion. Butyrate, therefore, increases MIP-2 secretion in stimulated cells by increasing histone acetylation. We speculate that butyrate carries information from bacteria to epithelial cells. Epithelial cells transduce this signal through histone deacetylase, modulating the secretion of chemokines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9294201      PMCID: PMC23353          DOI: 10.1073/pnas.94.19.10279

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Treatment of diversion colitis with short-chain-fatty acid irrigation.

Authors:  J M Harig; K H Soergel; R A Komorowski; C M Wood
Journal:  N Engl J Med       Date:  1989-01-05       Impact factor: 91.245

2.  A model of host-microbial interactions in an open mammalian ecosystem.

Authors:  L Bry; P G Falk; T Midtvedt; J I Gordon
Journal:  Science       Date:  1996-09-06       Impact factor: 47.728

Review 3.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.

Authors:  M Baggiolini; B Dewald; B Moser
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

Review 4.  Blind loop syndrome and small bowel bacterial contamination.

Authors:  P E Isaacs; Y S Kim
Journal:  Clin Gastroenterol       Date:  1983-05

5.  Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.

Authors:  F Cominelli; C C Nast; B D Clark; R Schindler; R Lierena; V E Eysselein; R C Thompson; C A Dinarello
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

6.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood.

Authors:  J H Cummings; E W Pomare; W J Branch; C P Naylor; G T Macfarlane
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

7.  Remission induced by an elemental diet in small bowel Crohn's disease.

Authors:  I R Sanderson; S Udeen; P S Davies; M O Savage; J A Walker-Smith
Journal:  Arch Dis Child       Date:  1987-02       Impact factor: 3.791

8.  Role for macrophage products in endotoxin-induced polymorphonuclear leukocyte accumulation during inflammation.

Authors:  A C Issekutz; P Megyeri; T B Issekutz
Journal:  Lab Invest       Date:  1987-01       Impact factor: 5.662

9.  Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease.

Authors:  P Gibson; O Rosella
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

10.  Regulation of C-fos expression by sodium butyrate in the human colon carcinoma cell line Caco-2.

Authors:  A Souleimani; C Asselin
Journal:  Biochem Biophys Res Commun       Date:  1993-05-28       Impact factor: 3.575

View more
  19 in total

1.  Breast milk lactoferrin regulates gene expression by binding bacterial DNA CpG motifs but not genomic DNA promoters in model intestinal cells.

Authors:  Peter Mulligan; Nicholas R J White; Giovanni Monteleone; Ping Wang; James W Wilson; Yoshi Ohtsuka; Ian R Sanderson
Journal:  Pediatr Res       Date:  2006-05       Impact factor: 3.756

Review 2.  Dietary modulation of GALT.

Authors:  Ian R Sanderson
Journal:  J Nutr       Date:  2007-11       Impact factor: 4.798

3.  Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases.

Authors:  Yuexing Zhang; Nicholas Woodford; Xianmin Xia; Anne W Hamburger
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

4.  Lipopolysaccharide induces CXCL2/macrophage inflammatory protein-2 gene expression in enterocytes via NF-kappaB activation: independence from endogenous TNF-alpha and platelet-activating factor.

Authors:  Isabelle G De Plaen; Xin-Bing Han; Xueli Liu; Wei Hsueh; Sankar Ghosh; Michael J May
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

5.  MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine.

Authors:  Y Ohtsuka; J Lee; D S Stamm; I R Sanderson
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

Review 6.  Chemokines in the inflammatory bowel diseases.

Authors:  R P MacDermott
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

7.  Butyrate switches the pattern of chemokine secretion by intestinal epithelial cells through histone acetylation.

Authors:  R D Fusunyan; J J Quinn; M Fujimoto; R P MacDermott; I R Sanderson
Journal:  Mol Med       Date:  1999-09       Impact factor: 6.354

8.  Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease.

Authors:  J P Segain; D Raingeard de la Blétière; A Bourreille; V Leray; N Gervois; C Rosales; L Ferrier; C Bonnet; H M Blottière; J P Galmiche
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

9.  Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis.

Authors:  Keqiang Chen; Mingyong Liu; Ying Liu; Teizo Yoshimura; Wei Shen; Yingying Le; Scott Durum; Wanghua Gong; Chunyan Wang; Ji-Liang Gao; Philip M Murphy; Ji Ming Wang
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

10.  Butyrate modulates intestinal epithelial cell-mediated neutrophil migration.

Authors:  U Böcker; T Nebe; F Herweck; L Holt; A Panja; C Jobin; S Rossol; R B Sartor; M V Singer
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.